Abstract:Background: Regulating the polarization of macrophages to antitumor M1 macrophages is a promising strategy for overcoming the immunosuppression of the tumor microenvironment for cancer therapy. Ferumoxytol (FMT) can not only serve as a drug deliver agent but also exerts anti-tumor activity. beta-glucan has immuno-modulating properties to prevent tumor growth. Thus, a nanocomposite of FMT surface-coated with beta-glucan (FMT-beta-glucan) was prepared to explore its effect on tumor suppression.Methods: Male B16F10 melanoma mouse model was established to explore the antitumor effect of FMT-beta-glucan. The viability and apoptotic rates of B16F10 cells were detected by cell counting kit-8 and Annexin-V/PI experiments. The levels of M1 markers were quantified by quantitative reverse transcription-polymerase chain reaction and enzyme linked immunosorbent assay. Phagocytic activity and intracellular reactive oxygen species (ROS) in macrophages were evaluated by the neutral red uptake assay and flow cytometry, respectively. Small interfering RNA (siRNA) transfection was applied to knock down the Dectin-1 gene in RAW 264.7 cells.Results: FMT-beta-glucan suppressed tumor growth to a greater extent and induced higher infiltration of M1 macrophages than the combination of FMT and beta-glucan (FMT+beta-glucan) in vivo. In vitro, supernatant from FMT-beta-glucan-treated RAW 264.7 cells led to lower cell viability and induced more apoptosis of B16F10 cells than that from the FMT+beta-glucan group. Moreover, FMT-beta-glucan boosted the expression of M1 type markers, and increased phagocytic activity and ROS in RAW 264.7 cells. Further research indicated that FMT-beta-glucan treatment promoted the level of Dectin-1 on the surface of RAW 264.7 cells and that knockdown of Dectin-1 abrogated the phosphorylation levels of several components in MAPK and NF-kappa B signaling.Conclusion: The nanocomposite FMT-beta-glucan suppressed melanoma growth by inducing the M1 macrophage-activated tumor microenvironment.

Polysaccharide isolated from Grifola frondosa eliminates myeloid-derived suppressor cells and inhibits tumor growth by enhancing T cells responses

Grifola Frondosa Polysaccharides Induce Breast Cancer Cell Apoptosis Via the Mitochondrial-Dependent Apoptotic Pathway

Grifolin Inhibits Tumor Cells Adhesion and Migration Via Suppressing Interplay Between PGC1α and Fra-1 / LSF- MMP2 / CD44 Axes.

A Water Polysaccharide-Protein Complex from Grifola Frondosa Inhibit the Growth of Subcutaneous but Not Peritoneal Colon Tumor under Fasting Condition

Antitumor and immunomodulatory activity of a water-soluble polysaccharide from Grifola frondosa

The structural characteristics of an acid-soluble polysaccharide from Grifola frondosa and its antitumor effects on H22-bearing mice

A cold-water extracted polysaccharide-protein complex from Grifola frondosa exhibited anti-tumor activity via TLR4-NF-κB signaling activation and gut microbiota modification in H22 tumor-bearing mice

[Anti-Tumor Effect of Polysaccharide from Grifola Frondosa and Its Influence on Immunological Function].

Purification, Characterization and Immunomodulatory Activity of a Novel Polysaccharide from Grifola Frondosa.

Particulate Β-Glucan Regulates the Immunosuppression of Granulocytic Myeloid-Derived Suppressor Cells by Inhibiting NFIA Expression.

Increased Circulating GrMyeloid-derived Suppressor Cells Correlated with Tumor Burden and Survival in Locally Advanced Cervical Cancer Patient

Cold-water extracts of Grifola frondosa and its purified active fraction inhibit hepatocellular carcinoma in vitro and in vivo.

Particulate Beta-Glucan Modulates Myeloid-Derived Suppressor Cells (MDSC) Activity in Tumor-Bearing Mice and Lung Cancer Patients (TUM4P.931)

Fibrinogen-like Protein 2 Promotes Tumor Immune Suppression by Regulating Cholesterol Metabolism in Myeloid-Derived Suppressor Cells

Anti-tumor Effect of an Acid Polysaccharide from Gracilaria lemaneiformis in H22-bearing Mice

Ferumoxytol-Beta-Glucan Inhibits Melanoma Growth Via Interacting With Dectin-1 To Polarize Macrophages Into M1 Phenotype

Correction: Yeast-Derived Particulate Β-Glucan Treatment Subverts the Suppression of Myeloid-Derived Suppressor Cells (MDSC) by Inducing Polymorphonuclear MDSC Apoptosis and Monocytic MDSC Differentiation to APC in Cancer.

Polysaccharide Agaricus blazei Murill stimulates myeloid derived suppressor cell differentiation from M2 to M1 type, which mediates inhibition of tumour immune‐evasion via the Toll‐like receptor 2 pathway

Dectin-1 Activation Subverts the Suppression of Myeloid-Derived Suppressor Cells by Inducing PMN-MDSC Apoptosis and Monocytic MDSC Differentiation to Potent Antigen-Presenting Cells in Cancer (TUM6P.961)

Ganoderma lucidum polysaccharide (GLP) enhances antitumor immune response by regulating differentiation and inhibition of MDSCs via a CARD9-NF-κB-IDO pathway

polysaccharides enhance antitumor immune responses by downregulating the differentiation of myeloid-derived suppressor cells and tumor-associated macrophages